Abbvie Inc share price logo

Abbvie Inc Share Price

NYSE: ABBV

Mega Cap

$218.11

+1.34

(+0.62%)

Live

as on

Abbvie Inc Stock Performance

as on November 7, 2025 at 1:39 am IST

  • Day's Low

    Day's High

    $215.65
    $219.68
    downward going graph

    1.13%

    Downside

    0.72%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $163.81
    $244.81
    downward going graph

    24.90%

    Downside

    12.24%

    Upside

    downward going graph

Abbvie Inc share price movements today

Previous Close
$216.77
Open
$216.09
Volume
1.9M
Day's Low - High
$215.65 - $219.68
52 Week Low - High
$163.81 - $244.81

Abbvie Inc Historical Returns

1 Month Return
-5.83 %
3 Month Return
+ 10.43 %
1 Year Return
+ 7.74 %
3 Year Return
+ 49.21 %
5 Year Return
+ 133.46 %

Abbvie Inc Stock Fundamentals & Key Indicators

Check Abbvie Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$381.4B

EPS (TTM)

10.644

Dividend Yield

3.10%

Quarterly Earnings Growth YOY

-0.89%

PE Ratio (TTM)

161.11

Industry PE ratio

18.176666666666666

PEG Ratio

0.4252

EBITDA

28.5B

Revenue (TTM)

59.6B

Profit Margin

4.00%

Return On Equity TTM

112.85%

Abbvie Inc Stock Valuation

Track how Abbvie Inc P/E has moved over time to understand its valuation trends.

Abbvie Inc in the last 5 years

  • Overview

  • Trends

Lowest (9.14x)

December 31, 2020

Industry (18.18x)

November 6, 2025

Today (161.11x)

November 6, 2025

Highest (18.93x)

March 31, 2025

LowHigh

Today’s Price to Earnings Ratio: 161.11x

Abbvie Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Abbvie Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$381.4B133.46%161.114.00%
BUY$811.7B548.6%43.8530.99%
BUY$450.2B30.76%17.9827.26%
BUY$216.2B37.75%12.5335.61%
BUY$209.5B5.01%10.9229.63%

Stock Returns calculator for Abbvie Inc Stock including INR - Dollar returns

The Abbvie Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Abbvie Inc investment value today

Current value as on today

₹1,13,440

Returns

₹13,440

(+13.44%)

Returns from Abbvie Inc Stock

₹8,405 (+8.4%)

Dollar Returns*

₹5,036 (+5.04%)

Analyst Recommendation on Abbvie Inc Stock

Based on 35 analysts

BUY

65.71%

Buy

34.29%

Hold

0.00%

Sell

Based on 35 analysts, 65.71% of analysts recommend a 'BUY' rating for Abbvie Inc. Average target price of $240.39

Abbvie Inc Share Price Target

Get share price movements and forecasts by analysts on Abbvie Inc.

What analysts predicted

9.27%UPSIDE

Target Price

$240.39

Current Price

$218.11

Analyzed by

35 Analysts

Target

$240.39

Abbvie Inc target price $240.39, a slight upside of 9.27% compared to current price of $218.11. According to 35 analysts rating.

Abbvie Inc Stock’s Investor Sentiment and Interest

Investment in Abbvie Inc Shares on INDmoney has grown by 25.05% over the past 30 days, indicating increased transactional activity.

Time period: to

Change:25.05% versus previous 30 day period

Search interest for Abbvie Inc Stock has increased by 15% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:15% versus previous 30 day period

Abbvie Inc Quarterly Profit & Loss

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Total Revenue
13,865
13,927
14,301
12,310
14,462
14,460
15,102
13,343
15,423
15,776
Gross Profit
9,625
7,442
8,597
8,216
10,260
10,248
10,706
9,341
13,020
12,386
Operating Income
4,513
2,281
3,195
2,798
3,998
3,831
-1,490
3,733
5,862
4,891
EBITDA
5,422
4,743
3,852
4,489
5,003
4,883
535
4,400
4,344
1,381
Interest Expense
552
555
564
660
726
720
702
700
740
667
Depreciation
2,260
2,235
2,076
2,074
2,131
2,079
2,102
2,039
2,050
-
Income Before Tax
2,610
1,953
1,212
1,755
2,146
2,084
-2,269
1,661
1,554
714
Income Tax Expense
583
172
388
383
773
520
-2,246
372
613
526
Net Income
2,024
1,778
822
1,369
1,370
1,561
-22
1,286
944
186
Net Profit Margin
14.60%
12.77%
5.75%
11.12%
9.47%
10.80%
-0.15%
9.64%
6.12%
1.18%

Abbvie Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2015
Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
22,859
25,638
28,216
32,753
33,266
45,804
56,197
58,054
54,318
56,334
Gross Profit
18,359
19,805
21,176
25,035
25,827
30,417
38,751
40,640
33,903
39,430
Operating Income
7,537
9,340
9,545
6,383
12,983
11,363
17,924
18,117
12,757
9,137
EBITDA
8,200
10,120
10,378
8,310
12,227
12,323
23,933
24,174
17,172
14,910
Interest Expense
719
1,047
1,150
1,348
1,784
2,454
2,423
2,230
2,224
2,808
Depreciation
-
-
1,501
1,765
2,017
6,471
8,521
8,467
8,698
8,386
Income Before Tax
6,645
7,884
7,727
5,197
8,426
3,398
12,989
13,477
6,250
3,716
Income Tax Expense
1,501
1,931
2,418
490
544
-1,224
1,440
1,632
1,377
-570
Net Income
5,144
5,953
5,309
5,687
7,882
4,616
11,542
11,836
4,863
4,278
Net Profit Margin
22.50%
23.22%
18.82%
17.36%
23.69%
10.08%
20.54%
20.39%
8.95%
7.59%

Abbvie Inc Quarterly Cash Flow

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Net Income
1,781
826
1,359
1,373
1,590
4,286
1,289
941
188
Operating Cash Flow
7,574
4,753
4,040
2,271
5,447
7,048
1,635
5,153
7,024
Investing Cash Flow
-369
-800
-9,588
-1,102
-8,256
-1,874
-735
-1,181
-3,264
Financing Cash Flow
-2,661
-4,449
10,819
-6,097
-3,072
-6,861
-1,258
-2,710
-4,590
Change in Cash
4,528
-473
5,253
-4,937
-5,873
-1,733
-349
1,292
-838

Abbvie Inc Annual Cash Flow

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
5,953
5,309
5,687
7,882
4,622
11,549
11,845
4,820
4,286
Operating Cash Flow
7,041
9,960
13,427
13,324
17,588
22,777
24,943
22,839
18,806
Investing Cash Flow
-6,074
-274
-1,006
596
-37,557
-2,344
-623
-2,009
-20,820
Financing Cash Flow
-3,928
-5,512
-14,396
18,708
-11,501
-19,039
-24,803
-17,222
-5,211
Change in Cash
-3,299
4,203
-2,014
32,635
-31,475
1,297
-545
3,613
-7,290

Mutual Funds that own Abbvie Inc Stock

Check out the Mutual Funds with significant holdings in Abbvie Inc.

Global Institutional Holdings in Abbvie Inc

Funds
Holdings
Vanguard Group Inc
10.04%
BlackRock Inc
8.35%
State Street Corp
4.53%
JPMorgan Chase & Co
3.24%
Morgan Stanley - Brokerage Accounts
2.36%

Abbvie Inc News & Key Events

  • img

    Today's Timeline - 03 November

    Mon, 06:51 PM

    -

    Analyst recommends staying long on AbbVie, citing strong year-to-date performance despite broader industry pressures.

    Mon, 07:46 PM

    -

    BofA lowers AbbVie price target to $248, maintains Neutral rating amid concerns over stock performance.

    Mon, 07:49 PM

    -

    Baron Health Care Fund adds AbbVie to its portfolio, citing strong growth potential in immunology and pipeline expansion.

  • img

    Today's Timeline - 03 November

    Mon, 08:05 PM

    -

    AbbVie exceeds revenue expectations in Q3, driven by immunology and neuroscience growth, but faces margin pressure.

    Tue, 05:15 AM

    -

    AbbVie shares climbed 11.8% over six months, driven by strong immunology drug performance despite Humira sales decline.

    Tue, 05:49 AM

    -

    AbbVie reports strong Q3 results, raising 2025 outlook despite Humira sales decline and aesthetics challenges.

Insights on Abbvie Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Abbvie Inc has shown positive revenue growth over the last three quarters. The company's revenue increased from $13.34 billion to $15.77 billion, reflecting an average growth of 7.9% each quarter.

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Eli Lilly And Company has given 159.0% return, outperforming this stock by 109.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Eli Lilly And Company has given 19.2% return, outperforming this stock by 11.5%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Abbvie Inc's net profit has decreased for the last three quarters, dropping from $1.28 billion to $186 million. This represents an average decline of 53.5% each quarter.

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, ABBV stock has moved down by -5.0%

About Abbvie Inc

AbbVie Inc. is a pharmaceutical company headquartered in North Chicago, Illinois. It is ranked 6th on the list of largest biomedical companies by revenue. Their primary product is Humira (adalimumab) ($21 billion in 2022 revenues, 37% of total), administered via injection. It is approved to treat autoimmune diseases including rheumatoid arthritis, Crohns disease, plaque psoriasis, and ulcerative colitis.
OrganisationAbbvie Inc
Headquarters1 North Waukegan Road, North Chicago, IL, United States, 60064-6400
IndustryHealth Technology
CEOMr. Robert A. Michael CPA
E-voting on sharesClick here to vote

Key Management of Abbvie Inc

Name

Title

Dr. Nicholas J. Donoghoe M.D.

Executive VP and Chief Business & Strategy Officer

Mr. Robert A. Michael CPA

CEO & Chairman of the Board

Mr. Perry C. Siatis

Executive VP, General Counsel & Secretary

Mr. Wulff-Erik von Borcke

Senior VP & President of Oncology

Dr. Roopal Thakkar M.D.

Executive VP of Research and Development & Chief Scientific Officer

Ms. Elizabeth Shea

Senior Vice President of Investor Relations

Mr. Demetris D. Crum

Executive VP & Chief Human Resources Officer

Mr. Scott T. Reents

Executive VP & CFO

Dr. Azita Saleki-Gerhardt Ph.D.

Executive VP & COO

Mr. Jeffrey Ryan Stewart

Executive VP & Chief Commercial Officer

FAQs

What is Abbvie Inc share price today?

Abbvie Inc share price today is $218.11 as on . Abbvie Inc share today touched a day high of $219.68 and a low of $215.65.

What is the 52 week high and 52 week low for Abbvie Inc share?

Abbvie Inc share touched a 52 week high of $244.81 on and a 52 week low of $163.81 on . Abbvie Inc stock price today i.e. is trending at $218.11,which is 10.91% down from its 52 week high and 33.15% up from its 52 week low.

What is Abbvie Inc's market capitalisation today?

Abbvie Inc market capitalisation is $0.38T as on .

How to invest in Abbvie Inc Stock (ABBV) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Abbvie Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Abbvie Inc Shares that will get you 0.0069 shares as per Abbvie Inc share price of $218.11 per share as on November 7, 2025 at 1:39 am IST.

What is the minimum amount required to buy Abbvie Inc Stock (ABBV) from India?

Indian investors can start investing in Abbvie Inc (ABBV) shares with as little as ₹88.566 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹885.66 in Abbvie Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Abbvie Inc share’s latest price of $218.11 as on November 7, 2025 at 1:39 am IST, you will get 0.0458 shares of Abbvie Inc. Learn more about fractional shares .

What are the returns that Abbvie Inc has given to Indian investors in the last 5 years?

Abbvie Inc stock has given 133.46% share price returns and 19.94% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?